C-reactive protein levels and survival in patients with moderate to very severe COPD.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Chest

• Publication date

  2008-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1378/chest.07-2433PMID 18339787
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• C-reactive protein: does it predict mortality?

  2007cited by this paper
• C-reactive protein as a predictor of prognosis in chronic obstructive pulmonary disease.

  2007cited by this paper
• Use of plasma biomarkers at exacerbation of chronic obstructive pulmonary disease.

  2006cited by this paper
• C-reactive protein and mortality in mild to moderate chronic obstructive pulmonary disease

  2006cited by this paper
• C-reactive protein is a strong independent predictor of death in type 2 diabetes: association with multiple facets of the metabolic syndrome.

  2006cited by this paper
• C-reactive Protein as a Predictor of Prognosis in COPD.

  2006cited by this paper
• C-reactive protein and cardiovascular disease: Weighing the evidence

  2006cited by this paper
• C-reactive protein levels and clinically important predictive outcomes in stable COPD patients

  2006cited by this paper
• Genetic determinants of C-reactive protein in COPD

  2006cited by this paper
• Outcomes and markers in the assessment of chronic obstructive pulmonary disease

  2006cited by this paper
• C-reactive Protein Is a Strong Predictor of Mortality in Hemodialysis Patients

  2006cited by this paper
• Systemic Inflammation in COPD: Is Genetic Susceptibility a Key Factor?

  2006cited by this paper
• C-reactive protein and risk of cardiovascular disease in men and women from the Framingham Heart Study.

  2005cited by this paper
• C-reactive protein in patients with COPD, control smokers and non-smokers

  2005cited by this paper
• Inspiratory-to-total lung capacity ratio predicts mortality in patients with chronic obstructive pulmonary disease.

  2005cited by this paper
• Systemic effects of chronic obstructive pulmonary disease.

  2005cited by this paper
• CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: report from the clinical practice discussion group.

  2004cited by this paper
• Burden and clinical features of chronic obstructive pulmonary disease (COPD).

  2004cited by this paper
• CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice Report From the Laboratory Science Discussion Group

  2004cited by this paper
• Effects of fluticasone on systemic markers of inflammation in chronic obstructive pulmonary disease.

  2004cited by this paper
• Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis

  2004cited by this paper
• The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease.

  2004cited by this paper
• CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: overview.

  2004cited by this paper
• Clinical application of C-reactive protein for cardiovascular disease detection and prevention.

  2003cited by this paper
• Obstructive and restrictive lung disease and markers of inflammation: data from the Third National Health and Nutrition Examination.

  2003cited by this paper
• C-reactive protein: a critical update.

  2003cited by this paper
• What do chronic obstructive pulmonary disease patients die from? Amultiple cause coding analysis

  2003cited by this paper
• ATS statement: guidelines for the six-minute walk test.

  2002cited by this paper
• Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary.

  2001cited by this paper
• Systemic effects of chronic obstructive pulmonary disease.

  2001cited by this paper
• Validation of a combined comorbidity index.

  1994cited by this paper

• Multi-omics biomarker detection in smoking induced COPD.

  2026cites this paper
• C-reactive protein predicts respiratory failure in chronic obstructive pulmonary disease: a cohort analysis from the UK Biobank.

  2026cites this paper
• Evaluating the Role of Serum C-Reactive Protein as a Biomarker among Patients with Chronic Obstructive Pulmonary Disease: A Cross-Sectional Study

  2025cites this paper
• New markers in chronic obstructive pulmonary disease.

  2024cites this paper
• Immune system benefits of pulmonary rehabilitation in chronic obstructive pulmonary disease.

  2024cites this paper
• The impact of body mass index on mortality in COPD: an updated dose–response meta-analysis

  2024cites this paper
• Elevated C-reactive protein and mortality risk among COPD patients

  2024influential citation
• Prognostic Value of Neutrophil to Lymphocyte Ratio for Predicting 90-Day Poor Outcomes in Hospitalized Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease

  2023cites this paper
• Inflammatory Biomarkers in Chronic Obstructive Pulmonary Disease

  2022cites this paper
• Brown adipose tissue is not associated with cachexia or increased mortality in a retrospective study of patients with cancer.

  2022cites this paper
• Correlation of COPD and Metabolic syndrome and role of serum CRP level as a marker of systemic inflammation

  2022cites this paper
• Use of Laboratory Tests and Their Prognostic Value in Patients with Stable Chronic Obstructive Pulmonary Disease.

  2022cites this paper
• Markers of systemic inflammation in COPD patients with obesity

  2020cites this paper
• A Comparison of Exercise Tolerance, Measures of Cardiac Response to Exercise and Serum Markers in Chronic Obstructive Pulmonary Disease

  2020cites this paper
• Diagnostic biomarkers of acute exacerbation of chronic obstructive pulmonary disease at elderly patients

  2019cites this paper
• Depletion of miR-380 mitigates human bronchial epithelial cells injury to improve chronic obstructive pulmonary disease through targeting CHRNA4.

  2019cites this paper
• CRP-Bestimmung: sinnvolle Steuerung der Antibiotikatherapie bei Exazerbationen

  2019cites this paper
• C-reactive protein as a biomarker of response to inhaled corticosteroids among patients with COPD.

  2019cites this paper
• Biomarkers and clinical outcomes in COPD: a systematic review and meta-analysis

  2019cites this paper
• The Relationship Between C Reactive Protein /Albumin Ratio And 1-Year Mortality In Hospitalized Elderly Copd Patients With Acute Exacerbation

  2019cites this paper
• Electrochemical methods for detection of biomarkers of Chronic Obstructive Pulmonary Disease in serum and saliva.

  2019cites this paper
• The relationship between hypoxia, inflammation, and airway obstruction with carotid intima-media thickness in Chronic Obstructive Pulmonary Disease (COPD)

  2019cites this paper
• Association of cardiovascular and musculoskeletal biomarkers with clinical outcomes in chronic obstructive pulmonary disease.

  2019cites this paper
• Immune activation in alpha-1 antitrypsin deficiency related and usual chronic obstructive pulmonary disease

  2018cites this paper
• Chronic obstructive pulmonary disease in over 16s: diagnosis and management

  2018cites this paper
• Risk factors for osteoporosis in male patients with chronic obstructive pulmonary disease in Taiwan

  2018cites this paper
• Factors associated with the rate of COPD exacerbations that require hospitalization.

  2017cites this paper
• Role of differential scanning calorimetry (DSC) in the staging of COPD

  2017cites this paper
• The use of cellular and molecular biomarkers to manage COPD exacerbations

  2017cites this paper
• C-reactive protein as A Marker o f Status o f Chronic Obstructive Pulmonary Disease ( COPD ) : A Prospective Study from PGIMS , Rohtak

  2017cites this paper
• Exploring the interplay between airway bacteria, airway inflammation, lung structure and skeletal muscle dysfunction in COPD

  2017cites this paper
• Chapter 57 – Acute Phase Reactants and the Concept of Inflammation

  2017cites this paper
• Changes in systemic inflammation markers and severity of symptoms in chronic obstructive pulmonary disease patients receiving adequate basic therapy

  2017cites this paper
• C-reactive protein level predicts mortality in COPD: a systematic review and meta-analysis

  2017cites this paper
• COPD-OSA Overlap Syndrome: Evolving Evidence Regarding Epidemiology, Clinical Consequences, and Management.

  2017cites this paper
• The Effect of Fatigue and Fatigue Intensity on Exercise Tolerance in Moderate COPD

  2016cites this paper
• Effects of a Hydro-ethanolic Extract of Scoparia dulcis on Systemic Inflammation and Cachexia in an Allergic Asthma Model

  2016cites this paper
• Biobehavioral Prognostic Factors in Chronic Obstructive Pulmonary Disease: Results From the INSPIRE-II Trial

  2016cites this paper
• Regulatory T Cells Contribute to the Inhibition of Radiation-Induced Acute Lung Inflammation via Bee Venom Phospholipase A2 in Mice

  2016cites this paper
• Psychische Gesundheit, Biomarker und Überleben bei der schweren COPD: eine Pilotstudie

  2016cites this paper
• Mental health, serum biomarkers and survival in severe COPD: a pilot study

  2016cites this paper
• Relationship between high-sensitivity C-reactive protein serum levels and the severity of coronary artery stenosis in patients with coronary artery disease

  2016cites this paper
• Prediction and prevention of exacerbations and mortality in patients with COPD

  2016cites this paper
• Comorbidity and Inflammatory Markers May Contribute to Predict Mortality of High-Risk Patients With Chronic Obstructive Pulmonary Disease Exacerbation

  2016cites this paper
• COPD and stroke: are systemic inflammation and oxidative stress the missing links?

  2016cites this paper
• Association of High Sensitive CRP Level and COPD Assessment Test Scores with Clinically Important Predictive Outcomes in Stable COPD Patients

  2015cites this paper
• Serum Angiopoietin-2 and C-reactive protein as biomarkers of acute exacerbations of chronic obstructive pulmonary diseases

  2015cites this paper
• Microalbuminuria and Hypoxemia in Patients with COPD

  2015cites this paper
• Growth Differentiation Factor-15 Is a Novel Biomarker Predicting Acute Exacerbation of Chronic Obstructive Pulmonary Disease

  2015cites this paper
• The inflammasome accelerates radiation-induced lung inflammation and fibrosis in mice.

  2015cites this paper
• Challenges and Current Efforts in the Development of Biomarkers for Chronic Inflammatory and Remodeling Conditions of the Lungs

  2015cites this paper
• Neutrophil-to-lymphocyte ratio, calprotectin and YKL-40 in patients with chronic obstructive pulmonary disease: correlations and 5-year mortality – a cohort study

  2015cites this paper
• Novel and Emerging Blood Biomarkers in Chronic Obstructive Pulmonary Disease

  2015cites this paper
• Cardiovascular comorbidity in chronic obstructive pulmonary disease: Biomarkers, vascular function and effects of statin treatment

  2015cites this paper
• Role of Serum Interleukin 6, Albumin and C-Reactive Protein in COPD Patients

  2015cites this paper
• Re-assessing the importance of FEV1decline

  2015cites this paper
• Should we treat chronic obstructive pulmonary disease as a cardiovascular disease?

  2015cites this paper
• The relation among to mortality rate, hospitalization period and inflammatory mediators in patients with chronic obstructive pulmonary disease attack on admission to emergency department

  2015cites this paper
• THE IMPORTANCE OF BIOMARKERS IN DIAGNOSTIC AND EVALUATION OF PROGNOSIS FOR PATIENTS WITH CARDIOVASCULAR AND PULMONARY PATHOLOGY

  2014cites this paper
• Cellular and molecular mechanisms of chronic obstructive pulmonary disease.

  2014cites this paper
• Anti-inflammatory and safety assessment of Polyscias fruticosa ( L . ) Harms ( Araliaceae ) leaf extract in ovalbumin-induced asthma

  2014cites this paper
• Surfactant protein D, Club cell protein 16, Pulmonary and activation-regulated chemokine, C-reactive protein, and Fibrinogen biomarker variation in chronic obstructive lung disease

  2014influential citation
• Prognostic Value of C-Reactive Protein, Leukocytes, and Vitamin D in Severe Chronic Obstructive Pulmonary Disease

  2014cites this paper
• Biomarkers in Chronic Obstructive Pulmonary Disease (COPD): Current Concerns and Future Prospects

  2014cites this paper
• Meta-analysis of routine blood tests as predictors of mortality in COPD

  2014cites this paper
• Inflammatory biomarkers in chronic obstructive pulmonary disease

  2014cites this paper
• A longitudinal evaluation of novel outcome measures in chronic obstructive pulmonary disease

  2014cites this paper
• Survival, quality of life and health resource use following hospitalisation for acute exacerbations of chronic obstructive pulmonary disease

  2013cites this paper
• 57 – Acute Phase Reactants and the Concept of Inflammation

  2013cites this paper
• Biomarkers of disease activity in COPD and emphysema

  2013cites this paper
• Systemic biomarkers in the evaluation and management of COPD patients: are we getting closer to clinical application?

  2013cites this paper
• Differential scanning calorimetry (DSC) of blood serum in chronic obstructive pulmonary disease (COPD)

  2013cites this paper
• Plasma YKL-40 and all-cause mortality in patients with chronic obstructive pulmonary disease

  2013cites this paper
• Revisión de biomarcadores en asma y EPOC

  2013cites this paper
• The effects of Gamijinhae-tang on elastase/lipopolysaccharide-induced lung inflammation in an animal model of acute lung injury

  2013cites this paper
• C-reactive protein as a prognostic marker in chronic obstructive pulmonary disease

  2013cites this paper
• Three-year follow-up of Interleukin 6 and C-reactive protein in chronic obstructive pulmonary disease

  2013cites this paper
• The Role of the High-Sensitivity C-Reactive Protein in Patients with Stable Non-Cystic Fibrosis Bronchiectasis

  2013cites this paper
• Serum C-reactive Protein Level and Distribution in Chronic Obstructive Pulmonary Disease Versus Healthy Controls: a Case–Control Study from Iran

  2013cites this paper
• Peptides d’élastine et inflammation pulmonaire au cours de la Broncho-Pneumopathie Chronique Obstructive (BPCO)

  2013cites this paper
• Fetuin-A is Associated with Disease Severity and Exacerbation Frequency in Patients with COPD

  2013cites this paper
• The role of systemic inflammatory biomarkers to predict mortality in chronic obstructive pulmonary disease

  2013cites this paper
• Comparison of arterial and venous blood biomarker levels in chronic obstructive pulmonary disease

  2013cites this paper
• Chronic obstructive pulmonary disease (COPD): Local and systemic disease

  2013cites this paper
• COPD: Biomarkers and Phenotypes

  2013cites this paper
• Rationale for Earlier Treatment in COPD: A Systematic Review of Published Literature in Mild-to-Moderate COPD

  2013cites this paper
• The use of biomarkers to explore inflammation and phenotypes during exacerbations of chronic obstructive pulmonary disease

  2012cites this paper
• Systemic inflammation and metabolic syndrome in stable COPD patients.

  2012cites this paper
• Body Mass Index and Mortality in Chronic Obstructive Pulmonary Disease: A Meta-Analysis

  2012cites this paper
• A&agr;-Val360: a marker of neutrophil elastase and COPD disease activity

  2012influential citation
• The expanding role of biomarkers in the assessment of smoking-related parenchymal lung diseases.

  2012cites this paper
• Biomarkers in obstructive respiratory diseases: an update.

  2012cites this paper
• Inflammatory biomarkers improve clinical prediction of mortality in chronic obstructive pulmonary disease.

  2012cites this paper
• Inflammatory and repair serum biomarker pattern. Association to clinical outcomes in COPD

  2012cites this paper
• Decreased soluble dipeptidyl peptidase IV activity as a potential serum biomarker for COPD.

  2012cites this paper
• Chronic systemic inflammatory syndrome in patients with AECOPD presenting to emergency department.

  2012cites this paper
• Vascular dysfunction in chronic obstructive pulmonary disease: current evidence and perspectives

  2012cites this paper
• Evaluation of the Significance of Circulating Insulin-Like Growth Factor-1 and C-Reactive Protein in Patients with Chronic Obstructive Pulmonary Disease

  2012cites this paper
• The importance of C-reactive protein and other inflammatory markers in patients with chronic obstructive pulmonary disease.

  2012influential citation
• Prevalence of osteoporosis and osteopenia in Thai COPD patients.

  2012cites this paper